Genprex, Inc.
GNPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,193 | $2,499 | $2,540 | $2,838 |
| G&A Expenses | $0 | $2,182 | $1,429 | $0 |
| SG&A Expenses | $1,153 | $2,182 | $1,429 | $1,497 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,346 | $4,682 | $3,969 | $4,335 |
| Operating Income | -$3,346 | -$4,682 | -$3,969 | -$4,336 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$453 | $7 | $5 | $5 |
| Pre-Tax Income | -$3,799 | -$4,675 | -$3,965 | -$4,330 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,799 | -$4,675 | -$3,965 | -$4,330 |
| % Margin | – | – | – | – |
| EPS | -5 | -8.5 | -13 | -21 |
| % Growth | 41.2% | 34.6% | 38.1% | – |
| EPS Diluted | -5 | -8.5 | -13 | -21 |
| Weighted Avg Shares Out | 761 | 552 | 305 | 217 |
| Weighted Avg Shares Out Dil | 761 | 552 | 305 | 217 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $7 | $5 | $5 |
| Interest Expense | – | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $2 | $2 | $0 |
| EBITDA | -$3,799 | -$4,682 | -$3,968 | -$4,330 |
| % Margin | – | – | – | – |